An in-depth look into available targeted therapies for non-small cell lung cancer (NSCLC). Includes EGFR, ALK/ROS1, VEGF, NTRK, c-MET, RET and BRAF inhibitors. challenge.mybiogate.com/inventory-non-…

A focus on RET therapies for NSCLC, including selpercatinib, pralsetinib, and RXDX-105. Featured companies: Eli Lilly, Blueprint Medicines, CStone Pharmaceuticals, Ignyta ow.ly/8ojM50C7Dlq

Dr. Ginger Ding presents industry research on CRISPR-Cas9. She discusses safety risks and potential solutions and compares two companies that use this gene editing technology: CRISPR Therapeutics & Editas Medicine. ow.ly/wD3m50CaC3l linkedin.com/feed/update/ur…

The Global Challenge is still ongoing! A CRO is looking to collaborate. They're looking for new innovative drugs and therapeutics in the field of biomedicine. For more information, to view submitted projects, and to submit your own, please click the link. challenge.mybiogate.com/cell-and-gene-…

Industry research on schizophrenia, including an explanation of what it is, why prescribing correctly for it can be challenging, and why researching and developing new drugs to treat it is difficult. 7 companies are highlighted. ow.ly/rCVv50CcO4G

A look into analgesics including the history behind pain's designation as the fifth vital sign, the opioid crisis in the US, an example showing prevalence of neck pain, and types of analgesics in China. Companies: Yangtze River, Hengrui, Chia Tai Tianqing ow.ly/KSTJ50CdPKm

A Chinese pharmaceutical company is looking to collaborate with an innovative company that has developed drugs for CNS treatment and is at a clinical I/II stage. ow.ly/SOfU50CfQA3

The second in a series, Dr. Ginger Ding presents research on CRISPR. In this article she focuses on the history of CRISPR in gene editing, in vitro vs in vivo editing, a comparison of CRISPR with ZFN and TALEN, and some rising starts within the industry. ow.ly/o8gC50CgWqa

A large pharmaceutical company in China is looking to collaborate with an innovative company that is designing an analgesic. Ideal projects are already market ready or in final clinical trial phases. ow.ly/gIj750Cj10H

Pt 2 of our industry research on the analgesic drug market. This article delves into history behind the opioid epidemic, types of analgesics, R&D trends away from opioids, and a global project introduction. Companies: Levicept, Nocion Therapeutics, Kineta ow.ly/aDNk50CjYya

A top tier company in China is looking to collaborate in multiple areas. If your company makes medical devices and you're looking to expand your business to China, this is a great opportunity! More information is provided at the link below. ow.ly/VuWQ50Cm6du

Today, Dr. Ginger Ding presents a trend interpretation on TIGIT, including which companies have projects in R&D, problems that companies have encountered, an evaluation of clinical trial data, and an explanation of TIGIT and Fc. ow.ly/jfEV50CojTK

A public Chinese pharmaceutical company is looking to collaborate with innovators that have designed diabetes products. Products should be mature and on the market. For more information, please click the link below. ow.ly/nLNM50CpssE

In today's article, we present industry research on migraine, what it is, current treatment options and their limits, the rise of anti CGRP migraine treatment and its advantages, and market prospects. ow.ly/ylvc50CqzjY

If you're an innovator with a medical imaging device and a desire to expand to China, the #MyBioGateChallenge may be right for you! Chinese companies are looking to collaborate with and invest in companies that are looking to open a branch in China. ow.ly/Q7ut50CsLM1

From the teams at MyBioGate and the CUBIO Innovation Center, a very Happy Thanksgiving to you and your family!

A leading ophthalmology company is looking for projects with whom they may collaborate. If you're an innovator with an ophthalmology device or drug and you're looking to expand to China, click the link below to find out more info and submit your project. ow.ly/68qH50CyH1l

Recently GeneScience and Foresee signed a licensing agreement. The article delves into current treatments for prostate cancer, the terms of the agreement, details on Foresee's GnRH therapy, and a market performance comparison. ow.ly/XQzE50CzMDJ challenge.mybiogate.com/?p=11330&et_fb…

If you're interested to see what some of the top healthcare companies were in China in 2020, this is the article for you! Companies include big names like TopAlliance, Zai Lab, Hengrui Medicine, BeiGene, Mindray and Humanwell. ow.ly/oQ8650CGSQe

In today's article, Dr. Ginger Ding presents a summary of NLRP3, including what NLRP3 is, why researching it is so difficult, recent NLRP3 company acquisitions, a retrospective case study, and a look into Novartis's business in NLRP3. challenge.mybiogate.com/could-nlrp3-be…